News | Prostate Cancer | October 19, 2023

Added risk links back to basic anatomy 

Radiation therapy is one of the most common treatments for prostate cancer

Dr. Kiran Nandalur (left), a radiologist with Corewell Health and principal investigator of a new study showing that a simple MRI scan could predict radiation side effects for prostate cancer, reviews patient images with his colleague Dr. James Relle. 


October 19, 2023 — A new Corewell Health study suggests that men who have longer prostatic urethras, the part of the urethra that travels through the prostate, may be at a higher risk of experiencing moderate, often chronic urinary side effects after receiving radiation for prostate cancer.   

To date, researchers have struggled to determine any risk factors that could shed light on who might experience these types of side effects ahead of time. But now, a simple MRI scan and a new metric to determine urethra length could change that. 

Results, now published in the journal Academic Radiology, indicate that for every 1-centimeter increase in length of the prostatic urethra shown on the MRIs of 361 men, patients were about 60% more likely to experience issues such as having the urgency to urinate as well as needing to urinate more often. Patients with a prostatic urethra length greater than 4.6 centimeters were nearly twice as likely to develop these symptoms.   

“We believe this particular area is more exposed to the radiation doses patients receive, resulting in direct inflammation,” said Kiran Nandalur, M.D., principal investigator of the study and a radiologist at Corewell Health. “While chronic moderate urinary side effects were more problematic in approximately 28% of participants after three years, the good news is less than 3% of men experienced severe urinary side effects.”  

According to Dr. Nandalur, there are very few known risk factors for those who will experience side effects after radiation and, in his study, factors such as type of radiation or underlying medical conditions were not predictive of symptoms. He said this underscores how challenging it has been previously to assess risk factors and highlights the need for novel and innovative methods such as the use of MRI technology in prostate cancer care.  

Radiation therapy is one of the most common treatments for prostate cancer and overall, it is considered very safe. However, while radiation therapy is well tolerated by most patients, the portion of men who experience more side effects often can find their quality of life impacted for periods of time.  

“Our novel MRI metric may help patients know beforehand what their risk is in developing these symptoms and help them make better and more informed decisions on a course of treatment that optimizes quality of life,” Nandalur said.  

He added: “Doctors also can look at ways to better spare the prostatic urethra area from radiation and potentially decrease the side effects.”  

Dr. Nandalur encourages patients to be proactive in their health and with their doctors.   

“I highly recommend patients talk with their urologist or radiation oncologist about getting a prostate MRI before therapy,” he said. “It is robust in diagnosing and evaluating the extent of prostate cancer and can potentially help patients maintain a better quality of life after undergoing treatment.”  

For more information: https://corewellhealth.org/


Related Content

News | Radiation Dose Management

April 25, 2024 — BIOTRONIK, a leading global medical technology company specializing in innovative cardiovascular and ...

Time April 25, 2024
arrow
News | Radiation Therapy

April 18, 2024 — Accuray Incorporated announced that as part of its commitment to advancing patient care the company has ...

Time April 18, 2024
arrow
News | FDA

April 18, 2024 — Lumicell, Inc., a privately held company focused on developing innovative fluorescence-guided imaging ...

Time April 18, 2024
arrow
News | Lung Imaging

April 17, 2024 — A Medicare policy requiring primary care providers (PCPs) to share in the decision-making with patients ...

Time April 17, 2024
arrow
News | Mammography

April 12, 2024 — Bayer and Hologic, Inc. announced a first-of-its-kind collaboration to deliver a coordinated solution ...

Time April 12, 2024
arrow
News | Mammography

April 12, 2024 — GE HealthCare, a leader in breast health technology and diagnostics, will feature its latest breast ...

Time April 12, 2024
arrow
News | Radiation Therapy

April 12, 2024 — RTsafe, a leading provider of quality assurance products and services in stereotactic radiosurgery, and ...

Time April 12, 2024
arrow
Feature | Radiation Oncology | By Melinda Taschetta-Millane

In a new 3-part video series on advancements in diagnostic radiology with Robert L. Bard, MD, PC, DABR, FASLMS ...

Time April 10, 2024
arrow
News | Artificial Intelligence

April 9, 2024 —PreciseDx, a leading innovator in oncology diagnostics leveraging Artificial Intelligence (AI) for ...

Time April 09, 2024
arrow
News | Artificial Intelligence

April 8, 2024 — Lunit, a leading provider of AI-powered solutions for cancer diagnostics and therapeutics, today ...

Time April 08, 2024
arrow
Subscribe Now